Cancer Research Network: a Research Resource within Health Care Delivery System
Page 2

The National Cancer Institute and the National Institutes of Health feel that CRN is an essental cancer resource stems from:

a) the availability of integrated access to clinical data for large, stable, and diverse patient populations that are available through the "parent" Health Maintenance Organizations (HMOs)

b) the expertise of CRN researchers in using large sets of clinical data

c) the availability of direct access to such large data sets of broad populations and populations of cancer patients, including patients with rare cancers or complex medical conditions.

The NCI and NIH are planning to grant a maximum grant amount of $20 million throughout the entire duration of the project, which is anticipated to range from 1-5 years.

Interested applicants can read more about the Cancer Research Network: a Research Resource within Health Care Delivery System project by visiting Topgovernmentgrants.com or the Grants.gov website.

Only member of the Cancer Research Network consortium are eligible to apply for this funding opportunity.

The Department of Health and Human Service, the primary agency funding th Cancer Research Network: a Research Resource within Health Care Delivery System project, is the US federal government's leading agency responsible for protecting the health of all Americans and providing necessary human services to all, especially those are least capable of helping themselves.

Cancer Research Network: a Research Resource within Health Care Delivery System
  Back to Page 1

About The Author Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. She also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Minor Use Minor Species Development of Drugs: Research Project Grant
The National Institutes of Health has partnered with the U.S. Food and Drug Administration (FDA) and the Center for Veterinary Medicine(CVM) in an effort to establish the Minor Use Minor Species Development of Drugs: Research Project Grant.

---

Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
The National Institutes of Health, in cooperation with the National Institute on Drug Abuse (NIDA), has recently established the Strategic Alliances for Medications Development to Treat Substance Use Disorder Program wherein both agencies seek to support the development of substance abuse drugs by leveraging the strengths of two or more organizations toward a common goal of medications development.

---

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program
In keeping with this mission, the National Institutes of Health has partnered with the Canadian Institutes of Health Research (CIHR), the National Heart, Lung, and Blood Institute (NHLBI), and the Institute of Circulatory and Respiratory Health (ICRH) to establish the Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program.

---